Publications

Browse Publications:

By Category:

• Research Papers (111)
• Abstract Posters (2)
• Presentations (6)

By Physician:

• David Charytan, MD (3)
• Alanna Coolong, MD (2)
• Donald E. Cutlip, MD (52)
• Ralph D'Agostino, PhD (2)
• Elazer R. Edelman, MD, PhD (0)
• Maurizio Fava, MD (0)
• Lawrence Garcia, MD (0)
• Ernest V. Gervino, Sc.D., FACSM (1)
• Michael Gibson, MD (2)
• Kalon K.L. Ho, MD, MSc (21)
• Michael Jaff, MD (0)
• Mark Josephson, MD (4)
• Joseph Massaro, PhD (5)
• Laura Mauri, MD (23)
• Andrew Nierenberg, MD (0)
• Mark H. Pollack, MD (1)
• Jeffrey J. Popma, MD (40)
• Matthew R. Reynolds, M.D, M.Sc. (9)
• Alexei Shvilkin, MD, PhD (0)
• Peter Zimetbaum, MD (20)

Publications From: Jeffrey J. Popma, MD

Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy. J Am Coll Cardiol. 2002 Nov 20;40(10):1882-8. Review.

Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries. J Am Coll Cardiol. 2003 Dec 3;42(11):2007-13.

Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):1075-82.

Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):536-42.

Effects of stent length and lesion length on coronary restenosis. Am J Cardiol. 2004 Jun 1;93(11):1340-6, A5.

Preintervention arterial remodeling affects clinical outcome following stenting: an intravascular ultrasound study. J Am Coll Cardiol. 2001 Mar 15;37(4):1031-5.

Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter. Am Heart J. 2001 Mar;141(3):353-9.

Coronary artery stenting in the aged. J Am Coll Cardiol. 2001 Mar 1;37(3):856-62.

Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol. 2001 Jan 15;87(2):152-6.

The PARAGON stent study: a randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions. Am J Cardiol. 2000 Nov 15;86(10):1073-9.

Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial. Am J Cardiol. 2002 Nov 15;90(10):1079-83.

Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses. Circulation. 2000 Sep 19;102(12):1364-8.

Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol. 2001 Jan 15;87(2):157-62.

Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation. 2008 Feb 12;117(6):790-7.

Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004 Oct 7;351(15):1493-501.

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998 Dec 3;339(23):1665-71.

The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J Am Coll Cardiol. 2007 Oct 9;50(15):1442-9.

Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Am J Cardiol. 2007 Sep 1;100(5):818-23.

Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol. 2006 Dec 19;48(12):2440-7.

Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II Trial. Minerva Cardioangiol. 2007 Feb

Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection. Eur Heart J. 2006 Apr;27(8):920-8.

Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. J Am Coll Cardiol. 2006 Jul 4;48(1):32-6.

Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA. 2006 Mar 15;295(11):1264-73.

Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents. Am J Cardiol. 2005 May 15;95(10):1140-5.

Gender-specific outcomes after sirolimus-eluting stent implantation. J Am Coll Cardiol. 2007 Nov 27;50(22):2111-6.

Comparison of PRE-dilatation vs direct stenting in coronary treatment using the Medtronic AVE S670 Coronary Stent System (the PREDICT trial).Am J Cardiol. 2001 Dec 15;88(12):1364-9.

Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.Circulation. 2002 Mar 19;105(11):1285-90.

Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox?Circulation. 2001 Aug 14;104(7):773-8.

Reproducibility of coronary lumen, plaque, and vessel wall reconstruction and of endothelial shear stress measurements in vivo in humans. Catheter Cardiovasc Interv. 2003 Sep;60(1):67-78.

Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation. 2001 Apr 17;103(15):1967-71.

Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol. 2002 Dec 18;40(12):2082-9.

Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2002 Dec 4;40(11):1928-34.

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation. 2004 Feb 10;109(5):634-40.

Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART). Am Heart J. 2003 May;145(5):84

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003 Oct 2;349(14):1315-23.

Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation. 2002 Aug 27;106(9):1090-6.

A decade of improvement in the clinical outcomes of percutaneous coronary intervention for multivessel coronary artery disease. Circulation. 2002 Sep 24;106(13):1592-4.

Incidence and predictors of late total occlusion following coronary stenting. Catheter Cardiovasc Interv. 2003 Nov;60(3):344-51.

A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]). Am J Cardiol. 2002 Feb 1;89(3):326-30.

Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003 Aug 5;108(5):548-53.

Meet The HCRI Team

Maria Francescon

Program Director CEC Special Projects

Maria Francescon began working at HCRI in 2002 within the Project Management Department. During 2003, she joined the Clinical Affairs…

Submit an RFP

Quick Links

• Contact HCRI
• Careers at HCRI
• Information for Patients

930-W Commonwealth Avenue
Boston MA 02215
t: 617.632.1515    f: 617.632.1580

©2008 Harvard Clinical Research Institute